Abstract

Diabetic retinopathy (DR) is one of the major complications of diabetes, which eventually leads to blindness. Up to date, no animal model has yet shown all the co-morbidities often observed in DR patients. Here, we investigated whether obese 42 weeks old ZSF1 rat, which spontaneously develops diabetes, hypertension and obesity, would be a suitable model to study DR. Although arteriolar tortuosity increased in retinas from obese as compared to lean (hypertensive only) ZSF1 rats, vascular density pericyte coverage, microglia number, vascular morphology and retinal thickness were not affected by diabetes. These results show that, despite high glucose levels, obese ZSF1 rats did not develop DR. Such observations prompted us to investigate whether the expression of genes, possibly able to contain DR development, was affected. Accordingly, mRNA sequencing analysis showed that genes (i.e. Npy and crystallins), known to have a protective role, were upregulated in retinas from obese ZSF1 rats. Lack of retina damage, despite obesity, hypertension and diabetes, makes the 42 weeks of age ZSF1 rats a suitable animal model to identify genes with a protective function in DR. Further characterisation of the identified genes and downstream pathways could provide more therapeutic targets for the treat DR.

Details

Title
Resistance to retinopathy development in obese, diabetic and hypertensive ZSF1 rats: an exciting model to identify protective genes
Author
Caolo, Vincenza 1   VIAFID ORCID Logo  ; Roblain, Quentin 2 ; Lecomte, Julie 3 ; Carai, Paolo 1 ; Peters, Linsey 4 ; Cuijpers, Ilona 5 ; Robinson, Emma Louise 4   VIAFID ORCID Logo  ; Derks, Kasper 6 ; Sergeys, Jurgen 7   VIAFID ORCID Logo  ; Noël, Agnès 3 ; Jones, Elizabeth A V 1 ; Moons, Lieve 7   VIAFID ORCID Logo  ; Heymans, Stephane 8 

 Department of Cardiovascular Sciences, Centre for Molecular and Vascular Biology, KU Leuven, Belgium 
 Department of Cardiology, CARIM School for Cardiovascular Diseases Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands; Laboratory of Tumor and Development Biology, GIGA-Cancer, University of Liège, Liège, Belgium 
 Laboratory of Tumor and Development Biology, GIGA-Cancer, University of Liège, Liège, Belgium 
 Department of Cardiology, CARIM School for Cardiovascular Diseases Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands 
 Department of Cardiovascular Sciences, Centre for Molecular and Vascular Biology, KU Leuven, Belgium; Department of Cardiology, CARIM School for Cardiovascular Diseases Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands 
 Department of Genetics and Cell Biology, CARIM School for Cardiovascular Diseases Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands 
 Laboratory of Neural Circuit Development and Regeneration, Animal Physiology and Neurobiology Section, Department of Biology, KU Leuven, Leuven, Belgium 
 Department of Cardiovascular Sciences, Centre for Molecular and Vascular Biology, KU Leuven, Belgium; Department of Cardiology, CARIM School for Cardiovascular Diseases Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands; The Netherlands Heart Institute, Utrecht, The Netherlands 
Pages
1-11
Publication year
2018
Publication date
Aug 2018
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2086244921
Copyright
© 2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.